GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 707 filers reported holding GLAXOSMITHKLINE PLC in Q1 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $328,000 | -10.4% | 7,569 | -16.1% | 0.24% | +2.5% |
| Q1 2016 | $366,000 | -0.5% | 9,017 | -1.2% | 0.24% | -3.2% |
| Q4 2015 | $368,000 | -20.3% | 9,129 | -24.0% | 0.25% | -29.2% |
| Q3 2015 | $462,000 | -10.3% | 12,004 | -2.8% | 0.35% | -4.1% |
| Q2 2015 | $515,000 | -12.3% | 12,354 | -2.9% | 0.36% | -10.3% |
| Q1 2015 | $587,000 | +5.6% | 12,728 | -2.1% | 0.41% | +2.5% |
| Q4 2014 | $556,000 | -23.2% | 12,998 | -17.4% | 0.40% | -28.8% |
| Q3 2014 | $724,000 | -19.0% | 15,744 | -5.8% | 0.56% | -18.8% |
| Q2 2014 | $894,000 | +44.9% | 16,712 | +27.0% | 0.68% | +23.4% |
| Q1 2014 | $617,000 | -15.5% | 13,158 | -3.8% | 0.56% | -6.4% |
| Q4 2013 | $730,000 | +7.0% | 13,677 | +0.5% | 0.59% | -0.2% |
| Q3 2013 | $682,000 | -2.6% | 13,603 | -3.0% | 0.59% | +14.7% |
| Q2 2013 | $700,000 | – | 14,018 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |